amyloidosis classification and epidemiology
Published 3 years ago • 90 plays • Length 3:05Download video MP4
Download video MP3
Similar videos
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
3:14
the impact of amyloid deposits in al amyloidosis
-
5:14
current status & updates in the management of al amyloidosis
-
0:52
tocilizumab for aa amyloidosis
-
1:23
the main goals of therapy in al amyloidosis
-
1:51
diagnosis and potential therapeutic options for aa amyloidosis
-
1:04
aa amyloidosis management
-
5:25
what is amyloidosis part 1: diagnosis | ahn cardiovascular institute
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
6:58
blood review series – emerging immunotherapies for hematologic diseases
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
3:21
insights into the management of systemic al amyloidosis
-
2:56
early vs. deferred transplantation in al amyloidosis
-
0:59
an overview of the most promising upcoming treatments for amyloidosis
-
1:10
exploring the next era of treating al amyloidosis: role of birtamimab
-
4:51
localized amyloidosis: symptoms and site of disease
-
3:01
novel promising agents and clinical trials in amyloidosis
-
1:33
rnai therapeutics for attr amyloidosis
-
0:46
an insight into novel measures being explored for the diagnosis of cardiac amyloidosis
-
4:05
al amyloidosis special session highlights: therapeutic advances and ongoing trials in the field
-
1:16
considering enrolment in clinical trials for patients with amyloidosis
-
2:43
the importance of the mdt to provide adequate treatment and care to patients with amyloidosis